Literature DB >> 25989296

Kaposi's sarcoma simulating verrucous syndrome.

Cassio Porto Ferreira1, Alice Miranda2, José Augusto da Costa Nery2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25989296      PMCID: PMC9427505          DOI: 10.1016/j.bjid.2015.04.001

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   3.257


× No keyword cloud information.

Report

Kaposi's sarcoma (KS) is a vascular lesion of low-grade malignant potential and is the most frequent neoplasm in acquired immunodeficiency syndrome (AIDS). Typical cases can present with erythematous or violaceous lesions, plaques or nodules, but the hyperkeratotic variants are rare. A 31-year-old woman presented with a 6-year history of intractable injury in the left foot with worsening in pain and difficulty walking. The patient had a positive serology for HIV and reported intermittent and irregular use of antiretroviral therapy. On examination, a vegetative lesion with 20 cm in its largest diameter located on the medial side and plantar region of the left foot (Fig. 1(1, 2)) was noted. Fungal, bacteria/mycobacteria cultures were negative. Skin biopsy revealed hyperkeratosis and dermis with proliferation of mesenchymal lineage cells with formation of malformed vessels with the presence of red blood cells out of the light thereof (Fig. 1A–C). KS is a vascular neoplasm from vascular and lymphatic endothelium caused by human herpesvirus 8. Four different types of KS are distinguished: classic (Mediterranean), endemic (African), iatrogenic (transplant-related), and epidemic (AIDS-related). Hyperkeratotic KS is a rarely described clinicopathalogic variant of KS. There is verrucous epidermal acanthosis and hyperkeratosis overlying an often fibrotic epidermis. The explanation for the hyperkeratotic variant of KS may be the high interstitial protein concentration that retains fluid in the connective tissue, in turn leading to chronic inflammation causing fibrosis and hyperkeratosis. Highly active antiretroviral therapy (HAART) has greatly changed the clinical course of HIV-infected patients and several epidemiological studies indicate a decrease of several opportunistic infections and Kaposi's sarcoma.
Fig. 1

(1) Hyperkeratotic KS on the medial side and plantar region of the left foot. (2) Hyperkeratotic KS (in more detail). Epidermis with hyperkeratosis (A) and dermis with proliferation of mesenchymal lineage cells and malformed vessels with the presence of red blood cells out of the light thereof (B and C).

(1) Hyperkeratotic KS on the medial side and plantar region of the left foot. (2) Hyperkeratotic KS (in more detail). Epidermis with hyperkeratosis (A) and dermis with proliferation of mesenchymal lineage cells and malformed vessels with the presence of red blood cells out of the light thereof (B and C).

Authors’ contributions

Cassio Porto Ferreira and José Augusto da Costa Nery contributed to clinical care and paper preparation. Alice Miranda contributed to laboratory diagnosis and paper preparation.

Role of funding source

None.

Ethics committee approval

CEP 14/2001 Instituto Oswaldo Cruz – CPqHEC/FIOCRUZ.

Conflicts of interest

The authors declare no conflicts of interest.
  4 in total

1.  Acquired immune deficiency syndrome-related hyperkeratotic Kaposi's sarcoma with severe lymphoedema: report of five cases.

Authors:  U R Hengge; K Stocks; M Goos
Journal:  Br J Dermatol       Date:  2000-03       Impact factor: 9.302

Review 2.  Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease.

Authors:  Salim Mohanna; Vicente Maco; Francisco Bravo; Eduardo Gotuzzo
Journal:  Int J Infect Dis       Date:  2005-09       Impact factor: 3.623

Review 3.  The changing epidemiology of HIV infection: new challenges for HIV palliative care.

Authors:  P Easterbrook; J Meadway
Journal:  J R Soc Med       Date:  2001-09       Impact factor: 5.344

4.  Histological variants of cutaneous Kaposi sarcoma.

Authors:  Wayne Grayson; Liron Pantanowitz
Journal:  Diagn Pathol       Date:  2008-07-25       Impact factor: 2.644

  4 in total
  1 in total

1.  Atypical Kaposi's sarcoma in young inmunocompetent patient.

Authors:  Josefa Sánchez-López; Santiago Pérez-Parra; María Librada Porriño-Bustamante; José Aneiros-Fernández; Ramón Naranjo-Sintes; María Antonia Fernández-Pugnaire
Journal:  An Bras Dermatol       Date:  2017       Impact factor: 1.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.